Maxmarc Pharmaceutical Private Limited
About Maxmarc Pharmaceutical Private Limited
Data last updated:
Maxmarc Pharmaceutical Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 May 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51397DL2021PTC381102. Its GSTIN is 10AAOCM5926G1ZI (Bihar).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rakesh Kumar Singh and Pradip Kumar.
Its last annual general meeting (AGM) was held on 23 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No 92 And 93 Khata No 63/3 Nagli Vihar Extension Baprola, Delhi, India – 110043.
As per the financials filed for FY 2025, the company reported a revenue of ₹17.08 Lakh, a growth of 69% compared to the previous year. For the same year it recorded a net profit of ₹52,675 (net margin 3.1%) and EBITDA of ₹85,718 (EBITDA margin 5%). Revenue has grown at a compounded annual rate (CAGR) of 73% over three years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressHouse No 92 And 93 Khata No 63/3 Nagli Vihar Extension Baprola, Delhi, India – 110043
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Maxmarc Pharmaceutical Private Limited
The main business activity of Maxmarc Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Maxmarc Pharmaceutical Private Limited FY 2025 filings available
Maxmarc Pharmaceutical Private Limited reported revenue of ₹17.08 Lakh (up 69% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Maxmarc Pharmaceutical Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 73% over three years, including 69% growth in the latest year. EBITDA rose 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Maxmarc Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | ₹85,718 | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹52,675 | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Maxmarc Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 5% | •••• | •••• | •••• |
| Net Profit Margin | 3.1% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Maxmarc Pharmaceutical are in the company report.
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Maxmarc Pharmaceutical Private Limited
Maxmarc Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| CR Design Studio (OPC) Private Limited | ₹17.09 Lakh (FY 2023) | •••• | •••• | •••• | Warangal, Telangana, India | |
| Eyeandeye Pharmaceuticals Private Limited | ₹17.09 Lakh (FY 2024) | •••• | •••• | 114.0% | •••• | Gorakhpur, Uttar Pradesh, India |
| Marsapollo Pharmatech Services Private Limited | ₹17.09 Lakh (FY 2024) | •••• | •••• | 801.0% | •••• | Gwalior, Madhya Pradesh, India |
| Absolute Life Sciences Private Limited | ₹17.09 Lakh (FY 2025) | •••• | •••• | -64.0% | •••• | Gamri Extn, Delhi, India |
| Vyapar Finance Limited | ₹17.09 Lakh (FY 2016) | •••• | •••• | 80.0% | •••• | Mumbai, Maharashtra, India |
| Maxmarc Pharmaceutical Private Limited this company | ₹17.08 Lakh (FY 2025) | •••• | •••• | 69.0% | •••• | Delhi, India |
| Asia Crystal Private Limited | ₹17.08 Lakh (FY 2025) | •••• | •••• | -84.0% | •••• | Erode, Tamil Nadu, India |
| Lucrum Engineering Private Limited | ₹17.07 Lakh (FY 2025) | •••• | •••• | -24.0% | •••• | Kolkata, West Bengal, India |
| Balasaheb Gond Patil Farmers Producer Company Limited | ₹17.07 Lakh (FY 2022) | •••• | •••• | -77.0% | •••• | Kallam, Maharashtra, India |
| Gagandeep Vinimay Private Limited | ₹17.07 Lakh (FY 2025) | •••• | •••• | -47.0% | •••• | Kolkata, West Bengal, India |
| Sant Bagdana Auto Industries Private Limited | ₹17.07 Lakh (FY 2024) | •••• | •••• | 26.0% | •••• | Ahmedabad, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Maxmarc Pharmaceutical by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Maxmarc Pharmaceutical Private Limited
Maxmarc Pharmaceutical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rakesh Kumar Singh | Director | 14 May 2021 | 5 Years 4 Months | Current |
| Pradip Kumar Also directs: Triomark Helping Foundation | Director | 25 Aug 2024 | 2 Years 1 Months | Current |
Ownership and Shareholding of Maxmarc Pharmaceutical Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Maxmarc Pharmaceutical Private Limited
Maxmarc Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Maxmarc Pharmaceutical Private Limited
Maxmarc Pharmaceutical Private Limited has a workforce of 0 employees as of Apr 07, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Maxmarc Pharmaceutical Private Limited
Maxmarc Pharmaceutical Private Limited has 3 board changes on record since 2021: 2 appointments and 1 cessation. The latest: Pradip Kumar was appointed as Director on 25 Aug 2024.
Credit Ratings, Litigation & Regulatory Alerts for Maxmarc Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Maxmarc Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Maxmarc Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Maxmarc Pharmaceutical Private Limited
Maxmarc Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAOCM5926G1ZI | Bihar | Active | 30 Aug 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Maxmarc Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Maxmarc Pharmaceutical Private Limited
Maxmarc Pharmaceutical is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 May 2021 (5+ years old) and is registered under CIN U51397DL2021PTC381102.
Maxmarc Pharmaceutical reported revenue of ₹17.08 Lakh for FY 2025 (up 69% YoY).
Maxmarc Pharmaceutical has 2 current directors:
- Rakesh Kumar Singh - Director
- Pradip Kumar - Director
Maxmarc Pharmaceutical reported a net profit of ₹52,675 (net margin 3.1%) and EBITDA of ₹85,718 (EBITDA margin 5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Maxmarc Pharmaceutical is 73% over three years. In the latest year (FY 2025) revenue rose 69%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Maxmarc Pharmaceutical is 10AAOCM5926G1ZI, registered in Bihar.
The CIN (Corporate Identification Number) of Maxmarc Pharmaceutical is U51397DL2021PTC381102. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maxmarc Pharmaceutical was incorporated on 14 May 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Maxmarc Pharmaceutical by revenue are CR Design Studio (OPC) Private Limited, Eyeandeye Pharmaceuticals Private Limited, Marsapollo Pharmatech Services Private Limited, Absolute Life Sciences Private Limited, Vyapar Finance Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Pradip Kumar was appointed as Director on 25 Aug 2024. Sweta Rani ceased to be Director on 25 Aug 2024. Rakesh Kumar Singh was appointed as Director on 14 May 2021.
The registered office of Maxmarc Pharmaceutical is at House No 92 And 93 Khata No 633 Nagli Vihar Extension Baprola, Delhi, India – 110043.